Abstract
The ability to adapt to stress is an important defensive function of a living body, and impairment of this ability may contribute to some stress-related disorders. Thus, the examination of brain mechanisms involved in stress adaptation could help to pave the way for new therapeutic strategies for stress-related affective disorders, such as anxiety and depression. The present review focuses on the roles of brain serotonin (5-hydroxytryptamine; 5-HT) neuronal systems, and especially 5-HT1A receptors, on the development of stress adaptation. Although animals exposed to acute stress stimuli exhibit various stress responses, these disappear after chronic exposure to the same type of stress stimuli, indicating the development of stress adaptation. The evidence obtained from studies using stress-adapted animals suggests that maintenance of the 5- HT neuronal response to stress stimuli together with down-regulation of 5-HT1A autoreceptors, as well as up-regulation of postsynaptic 5-HT1A receptors, may contribute to the formation of stress adaptation. In contrast, disappearance of the 5- HT neuronal response to stress stimuli and dysfunction of postsynaptic 5-HT1A receptors are observed in animals subjected to inadaptable stress stimuli. Furthermore, exogenous activation of 5-HT1A receptors by injection of 5-HT1A receptor agonists facilitates the ability to adapt to stressful situations, confirming that 5-HT1A receptors play an important role in the formation of stress adaptation. These findings suggest that the brain 5-HT neuronal system, and particularly 5- HT1A receptors, may play a key role in the development of stress adaptation, and maintenance of this system may be particularly important for preventing and / or treating affective disorders.
Keywords: 5-ht1a receptors, mediators, stress adaptation, stress-related affective disorders, anxiety, depression
Current Neuropharmacology
Title: Brain 5-HT1A Receptors as Important Mediators in the Development of Stress Adaptation
Volume: 1 Issue: 4
Author(s): Minoru Tsuji, Hiroshi Takeda and Teruhiko Matsumiya
Affiliation:
Keywords: 5-ht1a receptors, mediators, stress adaptation, stress-related affective disorders, anxiety, depression
Abstract: The ability to adapt to stress is an important defensive function of a living body, and impairment of this ability may contribute to some stress-related disorders. Thus, the examination of brain mechanisms involved in stress adaptation could help to pave the way for new therapeutic strategies for stress-related affective disorders, such as anxiety and depression. The present review focuses on the roles of brain serotonin (5-hydroxytryptamine; 5-HT) neuronal systems, and especially 5-HT1A receptors, on the development of stress adaptation. Although animals exposed to acute stress stimuli exhibit various stress responses, these disappear after chronic exposure to the same type of stress stimuli, indicating the development of stress adaptation. The evidence obtained from studies using stress-adapted animals suggests that maintenance of the 5- HT neuronal response to stress stimuli together with down-regulation of 5-HT1A autoreceptors, as well as up-regulation of postsynaptic 5-HT1A receptors, may contribute to the formation of stress adaptation. In contrast, disappearance of the 5- HT neuronal response to stress stimuli and dysfunction of postsynaptic 5-HT1A receptors are observed in animals subjected to inadaptable stress stimuli. Furthermore, exogenous activation of 5-HT1A receptors by injection of 5-HT1A receptor agonists facilitates the ability to adapt to stressful situations, confirming that 5-HT1A receptors play an important role in the formation of stress adaptation. These findings suggest that the brain 5-HT neuronal system, and particularly 5- HT1A receptors, may play a key role in the development of stress adaptation, and maintenance of this system may be particularly important for preventing and / or treating affective disorders.
Export Options
About this article
Cite this article as:
Tsuji Minoru, Takeda Hiroshi and Matsumiya Teruhiko, Brain 5-HT1A Receptors as Important Mediators in the Development of Stress Adaptation, Current Neuropharmacology 2003; 1 (4) . https://dx.doi.org/10.2174/1570159033477044
DOI https://dx.doi.org/10.2174/1570159033477044 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Radiolabelled Molecules for Imaging the Translocator Protein (18 kDa) Using Positron Emission Tomography
Current Medicinal Chemistry Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset
CNS & Neurological Disorders - Drug Targets Xenobiotic-Metabolizing Enzymes in Human Lung
Current Drug Metabolism Perspectives in Cell Cycle Regulation: Lessons from an Anoxic Vertebrate
Current Genomics Joint Effect of ABCA7 rs4147929 and Body Mass Index on Progression from Mild Cognitive Impairment to Alzheimer’s Disease: The Shanghai Aging Study
Current Alzheimer Research GSK3 at the Edge: Regulation of Developmental Specification and Cell Polarization
Current Drug Targets Therapeutic Targeting of Developmental Signaling Pathways in Medulloblastoma: Hedgehog, Notch, Wnt and Myc
Current Signal Transduction Therapy Ubiquitin Enzymes, Ubiquitin and Proteasome Activity in Blood Mononuclear Cells of MCI, Alzheimer and Parkinson Patients
Current Alzheimer Research Application of Radioisotopes in Inflammation
Current Medicinal Chemistry Editorial (Thematic Issues: Pharmacological Intervention for Down Syndrome Cognitive Deficits: Emerging Drug Targets)
CNS & Neurological Disorders - Drug Targets Delirium Secondary to Lamotrigine Toxicity
Current Drug Safety Thin, Stubby or Mushroom: Spine Pathology in Alzheimers Disease
Current Alzheimer Research Editorial (Thematic Issue: Targeting Anti-Cancer Agents and Cancer Treatments)
Anti-Cancer Agents in Medicinal Chemistry Induced Fit Docking and Automated QSAR Studies Reveal the ER-α Inhibitory Activity of <i>Cannabis sativa</i> in Breast Cancer
Recent Patents on Anti-Cancer Drug Discovery The Effect of Positive Mental Imagery on Labor Pain Tolerance in Primiparous Women Referred to Atieh Hospital of Hamadan, Iran, 2018: A Randomized Controlled Clinical Trial Study
Current Women`s Health Reviews Simultaneous Determination of Total Cortisol and Cortisone in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry: Method Development, Validation and Preliminary Clinical Application
Current Pharmaceutical Analysis Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Neurochemical Changes in the Brain After Fetal Exposure to Fluoxetine, A Serotonin Reuptake Inhibitor (SRI) in Rodents
Current Proteomics Advances in the Automotive Systems: An Overview of Dual-Clutch Transmissions
Recent Patents on Mechanical Engineering Bioactivity Guided Isolation of Quercetin as Anxiolytic Compound from Elaeocarpus ganitrus Beads
The Natural Products Journal